Perioperative anemia;Perioperative anämie

Anaesthesist

Volumn 50, Issue 2, 2001, Pages 73-86

  Kulier, A ^a   Gombotz, H ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

Author keywords

Allogeneic transfusion; Anemia, perioperative; Erythropoietin; Iron deficiency; Mortality

Indexed keywords

FERRITIN; HEMOGLOBIN; PROTOPORPHYRIN ZINC; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ANEMIA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; ERYTHROPOIESIS; HORMONAL THERAPY; HUMAN; INFLAMMATION; IRON DEFICIENCY; KIDNEY FAILURE; PATHOPHYSIOLOGY; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; SURGICAL MORTALITY; SURGICAL RISK; TREATMENT INDICATION;

AGED; ANEMIA; ERYTHROPOIETIN, RECOMBINANT; HUMANS; INTRAOPERATIVE COMPLICATIONS; INTRAOPERATIVE PERIOD;

EID: 0035107361     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050968     Document Type: Article

References (98)

1. Practice guidelines for blood component therapy
2. Erythropoietin for end-stage renal disease
3. Incidence of anemia in older people: An epidemiologic study in a well defined population
4. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
5. Post-operative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism
6. Effect of early blood transfusion on gastrointestinal haemorrhage
7. Allogeneic transfusion and infection: Economic and clinical implications
8. A prospective, randomized trial limiting perioperative red blood cell transfusions in vascular patients
9. Morbidity risk assessment in the surgically anemic patient
10. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair
11. Perioperative blood transfusion and postoperative mortality
12. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity
13. A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture
14. Recombinant human erythropoietin treatment in elderly cancer patients with cisplatin-associated anemia
15. Recombinant human erythropoietin treatment in cisplatin-associated anemia: A randomized, double-blind trial with placebo
16. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy
17. Use of recombinant human erythropoietin outside the setting of uremia
18. Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial
19. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy
20. Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial
21. Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery
22. Risk factors for postoperative morbidity
23. Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats
24. Influence of hematocrit on cardiopulmonary function after acute hemorrhage
25. Hematocrit and the risk of cardiovascular disease-the Framingham study: A 34-year follow-up
26. Preoperative treatment with recombinant human erythropoietin and predeposit of autologous blood in women undergoing primary hip replacement
27. Reduktion des Fremdblutverbrauchs in der operativen Medizin
28. Methods for reduction of perioperative bleeding
29. Transfusion medicine. First of two parts-blood transfusion
30. Erythropoietin therapy
31. Hyperoxaemia in extreme haemodilution
32. The effect of acute normovolemic hemodilution (ANH) on myocardial contractility in anesthetized dogs
33. The effect of hemodilution on regional myocardial function in the presence of coronary stenosis
34. Zinc protoporphyrin as screening test in female blood donors
35. Zinc protoporphyrin in anemia of chronic disorders
36. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care
37. Transfusion requirements in critical care. A pilot study
38. A Canadian survey of transfusion practices in critically ill patients
39. Does transfusion practice affect mortality in critically ill patients?
40. Risk of allogeneic transfusions
41. Modulation of immune response by blood transfusion: Evidence for a differential effect of allogeneic and autologous blood in colorectal cancer surgery
42. Experience with epoetin alfa and acquired immunodeficiency syndrome anemia
43. Maximizing oxygen delivery in critically ill patients: A methodologic appraisal of the evidence
44. Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy
45. The definition of anemia in older persons
46. Comparison of two transfusion strategies after elective operations for myocardial revascularization
47. A study of an educational intervention to decrease inappropriate preoperative autologous blood donation: Its effectiveness and the effect on subsequent transfusion rates in elective hysterectomy
48. Hemodilution in clinical surgery: State of the art 1996
49. Erythropoietin in patients undergoing coronary artery bypass graft surgery
50. Subcutaneous recombinant human erythropoietin and autologous blood donation before coronary artery bypass surgery
51. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints
52. A controlled trial of recombinant human erythropoietin after bone marrow transplantation
53. Effects of blood transfusion on oxygen transport variables in severe sepsis
54. Quality of life and anemia: The nephrology experience
55. A model that predicts morbidity and mortality after coronary artery bypass graft surgery
56. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants
57. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis
58. The evaluation of anemia
59. Progress in understanding the pathogenesis of the anemia of chronic disease
60. Management of preoperative anaemia
61. Proposal of an algorithm to help the choice of the best transfusion strategy
62. Decreased erythropoietin response in patients with the anemia of cancer
63. Human immunodeficiency virus infection, anemia, and survival
64. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit
65. Detrimental effects of perioperative blood transfusion
66. Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma - A randomized multi-center study
67. Outcome and risk factors of ischemic heart disease in chronic uremia
68. Recombinant human erythropoietin treatment: Investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results
69. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis
70. Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgery
71. Erythropoietin response is blunted in critically ill patients
72. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty
73. Blood transfusion facilitating difficult weaning from the ventilator
74. Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease
75. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease
76. Cardiovascular and coronary physiology of acute isovolemic hemodilution: A review of nonoxygen-carrying and oxygen-carrying solutions
77. Perioperative Transfusionskriterien
78. Hemodilution tolerance in patients with coronary artery disease who are receiving chronic beta-adrenergic blocker therapy
79. Elective surgery without transfusion: Influence of preoperative hemoglobin level and blood loss on mortality
80. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting
81. Cancer-related anemia: Its causes and characteristics
82. Recombinant human erythropoietin and the anemia of cancer
83. An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty
84. Safety of intravenous injection of iron saccharate in haemodialysis patients
85. Hemodilution and oxygen transport
86. Monitoring normovolaemic haemodilution
87. Erythropoietic response to acute and chronic anaemia: Focus on postoperative anaemia
88. Early transfusions and the length of survival in acquired immunodeficiency syndrome: Experience with a population receiving medical care at a public hospital
89. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease
90. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients
91. Myocardial ischaemia in anemic patients
92. Limitations of blood conservation
93. Human cardiovascular and metabolic response to acute, severe isovolemic anemia
94. Immune response and iron metabolism